We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Picosecond Ultrasonics Probe Human Cells

By LabMedica International staff writers
Posted on 13 Feb 2013
French researchers have employed high-frequency sound waves to examine the viscosity and stiffness of the nuclei of individual human cells. The scientists foresee that the probe could ultimately help resolve questions such as how cells bind to medical implants and why healthy cells become cancerous.

“We have developed a new noncontact, noninvasive tool to measure the mechanical properties of cells at the sub-cell scale,” stated Bertrand Audoin, a professor in the mechanics laboratory at the University of Bordeaux (France). “This can be useful to follow cell activity or identify cell disease.” The research was presented at the 57th annual meeting of the Biophysical Society (BPS), held February 2-6, 2013, in Philadelphia (PA, USA).

The technology that was used, called picosecond ultrasonics, was first applied in the electronics industry in the mid-1980s as a way to gauge the thickness of semiconductor chip layers. Prof. Audoin and his colleagues, in collaboration with a research group in biomaterials led by Marie-Christine Durrieu from the Institute of Chemistry & Biology of Membranes & Nano-objects at Bordeaux University, modified picosecond ultrasonics to research living cells. They grew cells on a metal plate and then flashed the cell-metal interface with an ultra-short laser pulse to generate high-frequency sound waves. Another laser measured how the sound pulse propagated through the cells, providing the investigators with insights into the mechanical characteristics of the individual cell components.

“The higher the frequency of sound you create, the smaller the wavelength, which means the smaller the objects you can probe,” stated Prof. Audoin. “We use gigahertz waves, so we can probe objects on the order of a hundred nanometers.” For comparison, a cell’s nucleus is about 10,000-nm wide.

The scientists faced hurdles in applying picosecond ultrasonics to study biologic systems. One challenge was the fluid-like substance characteristics of the cell. “The light scattering process we use to detect the mechanical properties of the cell is much weaker than for solids,” said Prof. Audoin. “We had to improve the signal to noise ratio without using a high-powered laser that would damage the cell.” The scientists also faced the challenge of natural cell variation. “If you probe silicon, you do it once, and it’s finished,” noted Prof. Audoin. “If you probe the nucleus you have to do it hundreds of times and look at the statistics.”

The investigators developed techniques to overcome these challenges by testing their techniques on polymer capsules and plant cells before moving on to human cells. In the coming years, the team envisions studying cancer cells with sound. “A cancerous tissue is stiffer than a healthy tissue,” noted Prof. Audoin. “If you can measure the rigidity of the cells while you provide different drugs, you can test if you are able to stop the cancer at the cell scale.”

Related Links:
University of Bordeaux

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Homocysteine Quality Control
Liquichek Homocysteine Control

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more